zaleplon
Generic: zaleplon
Labeler: bionpharma inc.Drug Facts
Product Profile
Brand Name
zaleplon
Generic Name
zaleplon
Labeler
bionpharma inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
zaleplon 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
69452-364
Product ID
69452-364_d0929d4c-0f84-40a4-94dc-6f80934e0edf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090374
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2024-02-17
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69452364
Hyphenated Format
69452-364
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
zaleplon (source: ndc)
Generic Name
zaleplon (source: ndc)
Application Number
ANDA090374 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (69452-364-20)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d0929d4c-0f84-40a4-94dc-6f80934e0edf", "openfda": {"nui": ["N0000183360", "N0000000196", "N0000175728"], "unii": ["S62U433RMH"], "rxcui": ["313761", "313762"], "spl_set_id": ["53103d2f-4453-49a8-9e36-888d919879f6"], "pharm_class_pe": ["Central Nervous System Depression [PE]"], "pharm_class_epc": ["gamma-Aminobutyric Acid A Receptor Agonist [EPC]"], "pharm_class_moa": ["GABA A Agonists [MoA]"], "manufacturer_name": ["Bionpharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69452-364-20)", "package_ndc": "69452-364-20", "marketing_start_date": "20240217"}], "brand_name": "Zaleplon", "product_id": "69452-364_d0929d4c-0f84-40a4-94dc-6f80934e0edf", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Depression [PE]", "GABA A Agonists [MoA]", "gamma-Aminobutyric Acid A Receptor Agonist [EPC]"], "product_ndc": "69452-364", "dea_schedule": "CIV", "generic_name": "Zaleplon", "labeler_name": "Bionpharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zaleplon", "active_ingredients": [{"name": "ZALEPLON", "strength": "5 mg/1"}], "application_number": "ANDA090374", "marketing_category": "ANDA", "marketing_start_date": "20240217", "listing_expiration_date": "20261231"}